Advertisement

Journal of Molecular Histology

, Volume 44, Issue 5, pp 555–563 | Cite as

ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma

  • Yehui Zhou
  • Jing Lan
  • Wei Wang
  • Qin Shi
  • Yang Lan
  • Zhiyi Cheng
  • Honggeng Guan
Original Paper

Abstract

E3 ubiquitin ligases regulate a variety of biological processes through the ubiquitin–proteasome system, together with ubiquitin activating enzyme E1 and ubiquitin-conjugating enzyme E2. Previous studies have demonstrated that zinc and ring finger 3 (ZNRF3), which belongs to the E3 ubiquitin ligases family is involved in the Wnt signalling pathway, which plays an important role in causing cancer. However, the expression and function of ZNRF3 in human gastric adenocarcinoma still remains unclear. Immunohistochemical and western blot analysis showed a significant down-regulation of ZNRF3 protein in gastric adenocarcinoma tissues compared with adjacent normal gastric tissues. In addition, there was a correlation between the down-regulation of ZNRF3 and poor tissue differentiation in gastric adenocarcinoma. To investigate the potential function of ZNRF3 in cell proliferation and apoptosis, a gastric cell line SGC7901 was employed. The over-expression of wild-type ZNRF3, which was accomplished by the transient transfection of recombinant pEGFP-ZNRF3 (or empty plasmids as control) into the cell line SGC7901, was confirmed by western blot analysis. Flow-cytometry-based and Cell Counting Kit-8 assays showed that over-expression of wt ZNRF3 induced apoptosis and suppressed proliferation. ZNRF3-overexpressing gastric cells displayed partly attenuated protein levels of beta-catenin and TCF-4 compared with those transfected with the empty plasmid. Our study demonstrates a novel gastric adenocarcinoma suppressor and reveals that ZNRF3 inhibits gastric cancer cell growth and promotes the cell apoptosis by affecting the Wnt/beta-catenin/TCF signalling pathway.

Keywords

ZNRF3 E3 ubiquitin ligases Gastric adenocarcinoma Wnt signalling Tumour suppressor 

References

  1. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R, Chan AS, Law S, Troyanskaya OG, Wong J et al (2003) Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 14:3208–3215PubMedCrossRefGoogle Scholar
  2. Cho LY, Yang JJ, Ko KP, Ma SH, Shin A, Choi BY, Han DS, Song KS, Kim YS, Chang SH et al (2012) Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk. PLoS ONE 7:e47603PubMedCrossRefGoogle Scholar
  3. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469–480PubMedCrossRefGoogle Scholar
  4. Clevers H, Nusse R (2012) Wnt/beta-catenin signaling and disease. Cell 149:1192–1205PubMedCrossRefGoogle Scholar
  5. Freese JL, Pino D, Pleasure SJ (2010) Wnt signaling in development and disease. Neurobiol Dis 38:148–153PubMedCrossRefGoogle Scholar
  6. Gencer S, Sen G, Dogusoy G, Belli AK, Paksoy M, Yazicioglu MB (2010) beta-Catenin-independent noncanonical Wnt pathway might be induced in gastric cancers. Turk J Gastroenterol 21:224–230PubMedGoogle Scholar
  7. Grossmann TN, Yeh JT, Bowman BR, Chu Q, Moellering RE, Verdine GL (2012) Inhibition of oncogenic Wnt signaling through direct targeting of beta-catenin. Proc Natl Acad Sci USA 109:17942–17947PubMedCrossRefGoogle Scholar
  8. Hao HX, Xie Y, Zhang Y, Charlat O, Oster E, Avello M, Lei H, Mickanin C, Liu D, Ruffner H et al (2012) ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485:195–200PubMedCrossRefGoogle Scholar
  9. Heo SH, Jeong ES, Lee KS, Seo JH, Jeong DG, Won YS, Kwon HJ, Kim HC, Kim DY, Choi YK (2012) Canonical Wnt signaling pathway plays an essential role in N-methyl-N-nitrosurea induced gastric tumorigenesis of mice. J Vet Med Sci [Epub ahead of print]Google Scholar
  10. Kim MS, Kim SS, Ahn CH, Yoo NJ, Lee SH (2009) Frameshift mutations of Wnt pathway genes AXIN2 and TCF7L2 in gastric carcinomas with high microsatellite instability. Hum Pathol 40:58–64PubMedCrossRefGoogle Scholar
  11. Kolligs FT, Bommer G, Goke B (2002) Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis. Digestion 66:131–144PubMedCrossRefGoogle Scholar
  12. Lowy AM, Clements WM, Bishop J, Kong L, Bonney T, Sisco K, Aronow B, Fenoglio-Preiser C, Groden J (2006) beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res 66:4734–4741PubMedCrossRefGoogle Scholar
  13. Ma J, Wang R, Fang X, Sun Z (2012) beta-Catenin/TCF-1 Pathway in T Cell Development and Differentiation. J Neuroimmune Pharmacol 7:750–762PubMedCrossRefGoogle Scholar
  14. MacDonald BT, He X (2012) A finger on the pulse of Wnt receptor signaling. Cell Res 22:1410–1412PubMedCrossRefGoogle Scholar
  15. Offerhaus GJ, Giardiello FM, Krush AJ, Booker SV, Tersmette AC, Kelley NC, Hamilton SR (1992) The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 102:1980–1982PubMedGoogle Scholar
  16. Ogasawara N, Tsukamoto T, Mizoshita T, Inada K, Cao X, Takenaka Y, Joh T, Tatematsu M (2006) Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 49:612–621PubMedCrossRefGoogle Scholar
  17. Okuno K, Sugiura F, Hida J, Tokoro T, Ishimaru E, Ueda K (2011) Preliminary study of Peptide vaccine with UFT/LV as adjuvant setting for stage III colorectal cancer. Gan To Kagaku Ryoho 38:1906–1908PubMedGoogle Scholar
  18. Parkin DM (2004) International variation. Oncogene 23:6329–6340PubMedCrossRefGoogle Scholar
  19. Pecina-Slaus N (2010) Wnt signal transduction pathway and apoptosis: a review. Cancer Cell Int 10:22PubMedCrossRefGoogle Scholar
  20. Remmele W, Stegner HE (1987) Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8:138–140PubMedGoogle Scholar
  21. Schepers A, Clevers H (2012) Wnt signaling, stem cells, and cancer of the gastrointestinal tract. Cold Spring Harb Perspect Biol 4:a007989PubMedCrossRefGoogle Scholar
  22. Smith MG, Hold GL, Tahara E, El-Omar EM (2006) Cellular and molecular aspects of gastric cancer. World J Gastroenterol 12:2979–2990PubMedGoogle Scholar
  23. Sun Y (2003) Targeting E3 ubiquitin ligases for cancer therapy. Cancer Biol Ther 2:623–629PubMedGoogle Scholar
  24. Sun Y (2006) E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia 8:645–654PubMedCrossRefGoogle Scholar
  25. Topol L, Jiang X, Choi H, Garrett-Beal L, Carolan PJ, Yang Y (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol 162:899–908PubMedCrossRefGoogle Scholar
  26. Turing AM (1990) The chemical basis of morphogenesis. 1953. Bull Math Biol 52:153–197; discussion 119–152Google Scholar
  27. Ushijima T, Sasako M (2004) Focus on gastric cancer. Cancer Cell 5:121–125PubMedCrossRefGoogle Scholar
  28. Wieman TJ, Taber SW, Reed DN Jr, Vitale GC (2003) Upper gastrointestinal cancer risk in familial adenomatous polyposis. J Ky Med Assoc 101:142–145PubMedGoogle Scholar
  29. Wolpert L (1969) Positional information and the spatial pattern of cellular differentiation. J Theor Biol 25:1–47PubMedCrossRefGoogle Scholar
  30. Wu J, Jiao Y, Dal Molin M, Maitra A, de Wilde RF, Wood LD, Eshleman JR, Goggins MG, Wolfgang CL, Canto MI et al (2011) Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci USA 108:21188–21193PubMedCrossRefGoogle Scholar
  31. Yagyu R, Furukawa Y, Lin YM, Shimokawa T, Yamamura T, Nakamura Y (2004) A novel oncoprotein RNF43 functions in an autocrine manner in colorectal cancer. Int J Oncol 25:1343–1348PubMedGoogle Scholar
  32. Yoshimatsu K, Yokomizo H, Osawa G, Fujimoto T, Otani T, Tsunoda T, Nakamura Y, Ogawa K (2008) Phase I study of combination therapy with peptide vaccine and anti-cancer drug for colorectal cancer. Gan To Kagaku Ryoho 35:2268–2270PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Yehui Zhou
    • 1
  • Jing Lan
    • 1
  • Wei Wang
    • 1
  • Qin Shi
    • 1
  • Yang Lan
    • 1
  • Zhiyi Cheng
    • 1
  • Honggeng Guan
    • 1
  1. 1.Department of General SurgeryThe First Affiliated Hospital of Soochow UniversitySuzhouPeople’s Republic of China

Personalised recommendations